These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19060419)

  • 1. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study.
    Ogawa S; Yamashita T; Yamazaki T; Aizawa Y; Atarashi H; Inoue H; Ohe T; Ohtsu H; Okumura K; Katoh T; Kamakura S; Kumagai K; Kurachi Y; Kodama I; Koretsune Y; Saikawa T; Sakurai M; Sugi K; Tabuchi T; Nakaya H; Nakayama T; Hirai M; Fukatani M; Mitamura H;
    Circ J; 2009 Feb; 73(2):242-8. PubMed ID: 19060419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antiarrhythmics used in patients with paroxysmal atrial fibrillation: subanalysis of J-RHYTHM Study.
    Aizawa Y; Kohsaka S; Suzuki S; Atarashi H; Kamakura S; Sakurai M; Nakaya H; Fukatani M; Mitamura H; Yamazaki T; Yamashita T; Ogawa S;
    Circ J; 2010 Jan; 74(1):71-6. PubMed ID: 19955694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of drug alteration to maintain rhythm control in paroxysmal atrial fibrillation. - Subanalysis from J-RHYTHM study -.
    Endo A; Kohsaka S; Suzuki S; Atarashi H; Kamakura S; Sakurai M; Nakaya H; Fukatani M; Mitamura H; Yamazaki T; Yamashita T; Ogawa S;
    Circ J; 2010 May; 74(5):870-5. PubMed ID: 20379004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of rate versus rhythm control in patients with atrial fibrillation and a pacemaker.
    Badheka AO; Marzouka GR; Rathod AD; Patel NJ; Myerburg RJ; Mitrani RD
    Am J Cardiol; 2013 Jun; 111(12):1759-63. PubMed ID: 23540545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the optimal treatment strategy for atrial fibrillation in Japan.
    Yamashita T; Ogawa S; Aizawa Y; Atarashi H; Inoue H; Ohe T; Okumura K; Kato T; Kamakura S; Kumagai K; Kurachi Y; Kodama I; Koretsune Y; Saikawa T; Sakurai M; Sugi K; Nakaya H; Nakayama T; Hirai M; Fukatani M; Mitamura H; Yamazaki T;
    Circ J; 2003 Sep; 67(9):738-41. PubMed ID: 12939546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study).
    Yamashita T; Inoue H; Okumura K; Kodama I; Aizawa Y; Atarashi H; Ohe T; Ohtsu H; Kato T; Kamakura S; Kumagai K; Kurachi Y; Koretsune Y; Saikawa T; Sakurai M; Sato T; Sugi K; Nakaya H; Hirai M; Hirayama A; Fukatani M; Mitamura H; Yamazaki T; Watanabe E; Ogawa S;
    Europace; 2011 Apr; 13(4):473-9. PubMed ID: 21148662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?
    Kong MH; Shaw LK; O'Connor C; Califf RM; Blazing MA; Al-Khatib SM
    Ann Noninvasive Electrocardiol; 2010 Jul; 15(3):209-17. PubMed ID: 20645962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic control of heart rate in atrial fibrillation.
    Falk RH
    Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation.
    Purmah Y; Proietti M; Laroche C; Mazurek M; Tahmatzidis D; Boriani G; Novo S; Lip GYH;
    Europace; 2018 Feb; 20(2):243-252. PubMed ID: 28160483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography.
    Wang YC; Lin LC; Lin MS; Lai LP; Hwang JJ; Tseng YZ; Tseng CD; Lin JL
    Cardiology; 2005; 104(4):202-9. PubMed ID: 16155395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate versus rhythm control in the management of patients with atrial fibrillation.
    Pelargonio G; Prystowsky EN
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):514-21. PubMed ID: 16186849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhythm-independent feature of heart rate dynamics common to atrial fibrillation and sinus rhythm in patients with paroxysmal atrial fibrillation.
    Sato K; Yamasaki F; Furuno T; Hamada T; Mukai S; Hayano J; Sugiura T; Doi Y
    J Cardiol; 2003 Dec; 42(6):269-76. PubMed ID: 14723019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological control of rate and maintenance of sinus rhythm.
    Ezekowitz MD; Lampert R
    J Thromb Thrombolysis; 1999 Jan; 7(1):33-8. PubMed ID: 10337358
    [No Abstract]   [Full Text] [Related]  

  • 16. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
    Le Heuzey JY; Breithardt G; Camm J; Crijns H; Dorian P; Kowey PR; Merioua I; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub W
    Am J Cardiol; 2010 Mar; 105(5):687-93. PubMed ID: 20185018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhythm control of atrial fibrillation in heart failure.
    Heijman J; Voigt N; Abu-Taha IH; Dobrev D
    Heart Fail Clin; 2013 Oct; 9(4):407-15, vii-viii. PubMed ID: 24054474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confounding factors in rate versus rhythm control trials in patients with atrial fibrillation: lessons from the strategies of treatment of atrial fibrillation (STAF) pilot study.
    Carlsson J; Boos C
    Card Electrophysiol Rev; 2003 Jun; 7(2):122-6. PubMed ID: 14618034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.
    Du X; Guo L; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Liu X; Yin H; Xuan J; Dong J; Ma C
    BMC Cardiovasc Disord; 2017 Jul; 17(1):204. PubMed ID: 28750608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of treatment crossovers on clinical outcomes in the rate and rhythm control strategies for atrial fibrillation: Insights from the AFFIRM (Atrial Fibrillation Follow-up Investigation of Rhythm Management) trial.
    Maan A; Zhang Z; Qin Z; Wang Y; Dudley S; Dabhadakar K; Refaat M; Mansour M; Ruskin JN; Heist EK
    Pacing Clin Electrophysiol; 2017 Jul; 40(7):770-778. PubMed ID: 28543286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.